374 related articles for article (PubMed ID: 6422760)
41. Pulsatile intravenous gonadotropin-releasing hormone for ovulation-induction in infertile women. II. Analysis of follicular and luteal phase responses.
Jansen RP; Handelsman DJ; Boylan LM; Conway A; Shearman RP; Fraser IS; Anderson JC
Fertil Steril; 1987 Jul; 48(1):39-44. PubMed ID: 3109964
[TBL] [Abstract][Full Text] [Related]
42. Ovulation induction with pulsatile gonadotropin-releasing hormone administration in patients with polycystic ovarian syndrome.
Ory SJ; London SN; Tyrey L; Hammond CB
Fertil Steril; 1985 Jan; 43(1):20-5. PubMed ID: 3880710
[TBL] [Abstract][Full Text] [Related]
43. Luteinizing hormone bioactivity in human menopausal gonadotropin/human chorionic gonadotropin-induced cycles.
Abuzeid MI; Yeoman R; Aksel S
Fertil Steril; 1987 Feb; 47(2):238-43. PubMed ID: 3102284
[TBL] [Abstract][Full Text] [Related]
44. Comparative study of hormonal dynamics in pregnant and nonpregnant cycles during pulsatile subcutaneous administration of human menopausal gonadotropin in anovulatory infertile women.
Nakamura Y; Yoshimura Y; Oda T; Shiokawa S; Yoshinaga A; Akiba M
Fertil Steril; 1993 Aug; 60(2):254-61. PubMed ID: 8339820
[TBL] [Abstract][Full Text] [Related]
45. Plasma hormones in human gonadotropin induced ovulation.
Wu CH
Obstet Gynecol; 1977 Mar; 49(3):308-13. PubMed ID: 840459
[TBL] [Abstract][Full Text] [Related]
46. Plasma melatonin profile and hormonal interactions in the menstrual cycles of anovulatory infertile women treated with gonadotropins.
Tang PL; Chan TY; Tang GW; Pang SF
Gynecol Obstet Invest; 1998; 45(4):247-52. PubMed ID: 9623790
[TBL] [Abstract][Full Text] [Related]
47. Ovulation induction.
March CM
J Reprod Med; 1993 May; 38(5):335-46. PubMed ID: 8320669
[TBL] [Abstract][Full Text] [Related]
48. Specific factors predict the response to pulsatile gonadotropin-releasing hormone therapy in polycystic ovarian syndrome.
Gill S; Taylor AE; Martin KA; Welt CK; Adams JM; Hall JE
J Clin Endocrinol Metab; 2001 Jun; 86(6):2428-36. PubMed ID: 11397835
[TBL] [Abstract][Full Text] [Related]
49. Shortened luteal phase after ovulation induction with human menopausal gonadotropin and human chorionic gonadotropin.
Olson JL; Rebar RW; Schreiber JR; Vaitukaitis JL
Fertil Steril; 1983 Mar; 39(3):284-91. PubMed ID: 6402386
[TBL] [Abstract][Full Text] [Related]
50. Induction of ovulation in amenorrheic patients with gonadotropin-releasing hormone and human menopausal gonadotropin.
Eckstein N; Vagman I; Eshel A; Naor Z; Ayalon D
Fertil Steril; 1985 Dec; 44(6):744-50. PubMed ID: 3935484
[TBL] [Abstract][Full Text] [Related]
51. Repeated transient hypergonadotropic amenorrhea during pharmacologic induction of multiple follicular development with exogenous gonadotropins.
Mais V; Melis GB; Antinori D; Paoletti AM; Strigini F; Guerriero S; de Ruggiero A; Fioretti P
J Endocrinol Invest; 1990 Oct; 13(9):749-52. PubMed ID: 2127280
[TBL] [Abstract][Full Text] [Related]
52. [Ovulation induction with pure FSH in anovulatory patients resistant to clomifene citrate].
Kably-Ambe A; Reyes-Cuervo H; Barrón-Vallejo J
Ginecol Obstet Mex; 1996 Jul; 64():293-6. PubMed ID: 8756188
[TBL] [Abstract][Full Text] [Related]
53. Ovulation induction with pulsatile gonadotropin-releasing hormone (GnRH) or gonadotropins in a case of hypothalamic amenorrhea and diabetes insipidus.
Georgopoulos NA; Markou KB; Pappas AP; Protonatariou A; Vagenakis GA; Sykiotis GP; Dimopoulos PA; Tzingounis VA
Gynecol Endocrinol; 2001 Dec; 15(6):421-5. PubMed ID: 11826765
[TBL] [Abstract][Full Text] [Related]
54. Pulsatile GnRH therapy for the induction of ovulation in hypogonadotropic hypogonadism.
Blunt SM; Butt WR
Acta Endocrinol Suppl (Copenh); 1988; 288():58-65. PubMed ID: 3138867
[TBL] [Abstract][Full Text] [Related]
55. A combination of gonadotropin-releasing hormone analog and human menopausal gonadotropins for ovulation induction in premature ovarian failure.
Letterie G; Miyazawa K
Acta Obstet Gynecol Scand; 1989; 68(6):571-3. PubMed ID: 2520819
[TBL] [Abstract][Full Text] [Related]
56. Biochemical and biophysical indices of follicular development in spontaneous and stimulated ovulatory cycles.
Fossum GT; Vermesh M; Kletzky OA
Obstet Gynecol; 1990 Mar; 75(3 Pt 1):407-11. PubMed ID: 2106108
[TBL] [Abstract][Full Text] [Related]
57. Clinical experience in the induction of ovulation and pregnancy with pulsatile subcutaneous administration of human menopausal gonadotropin: a low incidence of multiple pregnancy.
Nakamura Y; Yoshimura Y; Yamada H; Ubukata Y; Yoshida K; Tamaoka Y; Suzuki M
Fertil Steril; 1989 Mar; 51(3):423-9. PubMed ID: 2493402
[TBL] [Abstract][Full Text] [Related]
58. Induction of ovulation with pulsatile gonadotropin releasing hormone (GnRH) in anovulatory women.
Cignitti M; Mazzarini A; Pini A; Garzetti GG; Romanini C
Acta Eur Fertil; 1990; 21(5):235-8. PubMed ID: 2132474
[TBL] [Abstract][Full Text] [Related]
59. Reduction of dehydroepiandrosterone sulfate synthesis in women with polycystic ovary syndrome by human menopausal gonadotropin but not purified urinary follicle stimulating hormone: a comparative pilot study.
Turkmen S; Backstrom T; Idil M
Gynecol Endocrinol; 2004 Aug; 19(2):69-78. PubMed ID: 15624268
[TBL] [Abstract][Full Text] [Related]
60. Human gonadotropin therapy. II. Serum estradiol and progesterone patterns during nonconceptual cycles.
Bergquist C; Nillius SJ; Wide L
Fertil Steril; 1983 Jun; 39(6):766-71. PubMed ID: 6406270
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
